prescription drug monitoring program
Recently Published Documents


TOTAL DOCUMENTS

158
(FIVE YEARS 71)

H-INDEX

19
(FIVE YEARS 5)

Author(s):  
Someshwar D. Mankar ◽  
Abhijit S. Navale ◽  
Suraj R. Kadam

Nowadays Prescription Opioid Abuse has become a serious problem, to monitor and reduce Opioid Abuse most of countries developed Prescription Drug Monitoring Program (PDMP). Regarding to this we conduct a systematic review to understanding the PDMP impact in order to reduce Opioid Abuse and improving prescriber practices. This review can help to guide efforts to better response to the Opioid crises.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Brian A. Karamian ◽  
Hareindra Jeyamohan ◽  
Paul D. Minetos ◽  
Parth Kothari ◽  
Jose A. Canseco ◽  
...  

Author(s):  
Samuel J. Rubin ◽  
Judy J. Wang ◽  
Ariana Y. Nodoushani ◽  
Bharat B. Yarlagadda ◽  
Jacqueline A. Wulu ◽  
...  

2021 ◽  
Vol 2 (10) ◽  
pp. e212924
Author(s):  
Rivfka Shenoy ◽  
Zachary Wagner ◽  
Allison Kirkegaard ◽  
Robert J. Romanelli ◽  
Satish Mudiganti ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Wangping Xiong ◽  
Jun Cao ◽  
Xian Zhou ◽  
Jianqiang Du ◽  
Bin Nie ◽  
...  

Background. Chinese patent medicines are increasingly used clinically, and the prescription drug monitoring program is an effective tool to promote drug safety and maintain health. Methods. We constructed a prescription drug monitoring program for Chinese patent medicines based on knowledge graphs. First, we extracted the key information of Chinese patent medicines, diseases, and symptoms from the domain-specific corpus by the information extraction. Second, based on the extracted entities and relationships, a knowledge graph was constructed to form a rule base for the monitoring of data. Then, the named entity recognition model extracted the key information from the electronic medical record to be monitored and matched the knowledge graph to realize the monitoring of the Chinese patent medicines in the prescription. Results. Named entity recognition based on the pretrained model achieved an F1 value of 83.3% on the Chinese patent medicines dataset. On the basis of entity recognition technology and knowledge graph, we implemented a prescription drug monitoring program for Chinese patent medicines. The accuracy rate of combined medication monitoring of three or more drugs of the program increased from 68% to 86.4%. The accuracy rate of drug control monitoring increased from 70% to 97%. The response time for conflicting prescriptions with two drugs was shortened from 1.3S to 0.8S. The response time for conflicting prescriptions with three or more drugs was shortened from 5.2S to 1.4S. Conclusions. The program constructed in this study can respond quickly and improve the efficiency of monitoring prescriptions. It is of great significance to ensure the safety of patients’ medication.


Sign in / Sign up

Export Citation Format

Share Document